Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
Ilyda SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €1.67 |
52 Week High | €1.90 |
52 Week Low | €1.12 |
Beta | 1.04 |
11 Month Change | 5.36% |
3 Month Change | 0.60% |
1 Year Change | 45.85% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 60.58% |
Recent News & Updates
Recent updates
Shareholder Returns
IY3A | DE Software | DE Market | |
---|---|---|---|
7D | 5.7% | -1.7% | -1.0% |
1Y | 45.9% | 60.7% | 12.8% |
Return vs Industry: IY3A underperformed the German Software industry which returned 60.7% over the past year.
Return vs Market: IY3A exceeded the German Market which returned 12.8% over the past year.
Price Volatility
IY3A volatility | |
---|---|
IY3A Average Weekly Movement | 5.4% |
Software Industry Average Movement | 4.9% |
Market Average Movement | 4.9% |
10% most volatile stocks in DE Market | 11.1% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: IY3A has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: IY3A's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1992 | 46 | Vasileios Apostolou | www.ilyda.com |
Ilyda SA engages in software development business in Greece. It offers enterprise resource planning systems, such as MegaTron ERP and Kinitron Smart ERP; Dioscourides Smart, Dioscourides Touch XPress, and Dioscourides ERP Retail System for pharmacies; MegaTron Pharma ERP for drugstores; and LIS Bio-Diagnosis for microbiological laboratories. The company also provides MegaTron DEVA for water supply/sewerage companies; PSIS Financial Management for public sector companies; PSIS Payroll & Personnel Management for legal entities; and SIS Secretariats of Educational Institutions for educational institutions.
Ilyda SA Fundamentals Summary
IY3A fundamental statistics | |
---|---|
Market cap | €16.51m |
Earnings (TTM) | €1.65m |
Revenue (TTM) | €4.84m |
10.0x
P/E Ratio3.4x
P/S RatioIs IY3A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
IY3A income statement (TTM) | |
---|---|
Revenue | €4.84m |
Cost of Revenue | €1.95m |
Gross Profit | €2.89m |
Other Expenses | €1.24m |
Earnings | €1.65m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.18 |
Gross Margin | 59.77% |
Net Profit Margin | 34.16% |
Debt/Equity Ratio | 0.2% |
How did IY3A perform over the long term?
See historical performance and comparison